Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ebola treatment trial of ZMapp plus optimized standard of care versus optimized standard of care
PACTR201503001065306Recruiting
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Mar 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 4
01
Overview
Randomised, open-label trial in Ebola virus disease (EVD) comparing ZMapp + optimized standard of care with Optimized standard of care (2 arms). Primary endpoint: Mortality. Started Mar 2015; status: recruiting.
02
Drugs
ZMapp
03
Conditions
Ebola virus disease (EVD)
Beyond the preview
Go deeper on PACTR201503001065306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201503001065306.